Description

Gentamicin + Clotrimazole + Beclomethasone + Lignocaine Ear Drops is a combination ENT formulation containing an antibacterial agent, antifungal agent, corticosteroid and local anesthetic.

Gentamicin provides antibacterial activity against susceptible bacteria, while Clotrimazole provides antifungal activity. Beclomethasone helps reduce inflammation, redness and swelling, and Lignocaine provides localized relief from ear discomfort.

The combination can be positioned within an ENT pharma franchise portfolio for use under appropriate medical supervision.

Key Benefits

• Combines antibacterial, antifungal, anti-inflammatory and local anesthetic components.
• Gentamicin helps address susceptible bacterial organisms.
• Clotrimazole provides antifungal activity.
• Beclomethasone helps reduce localized inflammation.
• Lignocaine provides symptomatic relief from local ear discomfort.
• Convenient ear-drop dosage form.
• Suitable addition to an ENT pharma franchise product portfolio.

Composition

Active ingredients:

• Gentamicin
• Clotrimazole
• Beclomethasone
• Lignocaine

Exact strengths should be confirmed against the final approved product specification.

Indications / Uses

This combination may be prescribed for selected external ear conditions involving susceptible microbial infection, inflammation and associated discomfort, depending on clinical assessment.

Potential applications may include:

• Otitis externa
• Bacterial or fungal infections of the external ear
• Ear inflammation associated with susceptible infection
• Ear discomfort associated with appropriate external-ear conditions

Important: The presence of a corticosteroid and aminoglycoside means this formulation should be used only when clinically appropriate and as directed by a qualified healthcare professional.

Dosage Form

Ear Drops

Administer into the affected ear as prescribed by the physician or ENT specialist.

Packaging

Available in a convenient ear-drop bottle, subject to the final marketed pack configuration.

Pharma Franchise Opportunity

Gentamicin + Clotrimazole + Beclomethasone + Lignocaine Ear Drops can be included in an ENT pharma franchise portfolio targeting ENT specialists, physicians, clinics and hospitals.

The combination provides multiple therapeutic components in a single topical ENT formulation, making it a potential addition to a broader PCD pharma franchise range focused on ear, nose and throat care.

Why Choose This ENT Ear Drop?

• Multi-component ENT formulation
• Combines antibacterial and antifungal activity with anti-inflammatory and local anesthetic properties
• Convenient topical ear-drop format
• Suitable for inclusion in ENT-focused pharmaceutical portfolios
• Potential fit for ENT PCD pharma franchise and specialty-care product ranges